Prothena Corporation Public (NASDAQ: PRTA) revenue
Prothena Corporation Public reported revenue of $9.7m for fiscal 2025, 92.8% less than in fiscal 2024 ($135.2m). Since fiscal 2016 its revenue has grown by 817.9%, an average growth of 27.9% a year.
Prothena Corporation Public's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2018, −96.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $9.7m | −92.8% | −$214.6m | −2,216.4% |
| 2024 | $135.2m | +47.9% | −$154.6m | −114.4% |
| 2023 | $91.4m | +69.5% | −$191.0m | −209.1% |
| 2022 | $53.9m | −73.1% | −$131.6m | −244.1% |
| 2021 | $200.6m | +23,414.3% | $72.0m | 35.9% |
| 2020 | $0.9m | +4.8% | −$112.7m | −13,216.2% |
| 2019 | $0.8m | −14.8% | −$85.7m | −10,527.9% |
| 2018 | $1.0m | −96.5% | −$158.9m | −16,634.0% |
| 2017 | $27.5m | +2,508.4% | −$155.3m | −564.2% |
| 2016 | $1.1m | — | −$159.5m | −15,121.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Prothena Corporation Public revenue compared with its sector
By revenue for its latest fiscal year, Prothena Corporation Public ranks 371st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Prothena Corporation Public, −92.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 369th | Taysha Gene Therapies | $9.8m | 17.3% |
| 370th | Precigen | $9.7m | 146.7% |
| 371st | Prothena Corporation Public | $9.7m | −92.8% |
| 372nd | Bioage Labs | $9.0m | — |
| 373rd | Roivant Sciences | $8.3m | −71.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Prothena Corporation Public
- How much revenue did Prothena Corporation Public make in fiscal 2025?
- Prothena Corporation Public reported revenue of $9.7m for fiscal 2025, compared with $135.2m in fiscal 2024.
- How much has the revenue of Prothena Corporation Public grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.1m to $9.7m: 817.9% more, an average growth of 27.9% a year.
- What was the best year for revenue at Prothena Corporation Public?
- Of its last 10 fiscal years, fiscal 2021, with $200.6m.
- Where does Prothena Corporation Public rank in its sector by revenue?
- It ranks 371st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Prothena Corporation Public come from?
- From the annual report (Form 10-K) that Prothena Corporation Public files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Prothena Corporation Public files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Prothena Corporation Public: the Prothena Corporation Public page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.